News
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos
GSK has taken another step towards rebuilding its respiratory pipeline with a $1.4 billion agreement to buy Aiolos Bio and its lead drug AIO-001 for asthma and other indic